Skip to main content

Featured

Nations React to Reported $1 Billion Fee for Trump’s Peace Board

  President Trump said the Peace Board 'will embark on a new approach to resolving global conflict'. Reports surrounding President Donald Trump’s proposed Board of Peace have ignited global debate after claims surfaced that countries may be asked to contribute $1 billion to secure or maintain permanent membership. The board, envisioned as a body overseeing governance and reconstruction efforts in Gaza, would reportedly be chaired by Trump himself, who would hold authority over which nations are admitted. A draft charter circulating among diplomats outlines three‑year membership terms, renewable only with the chairman’s approval. It also suggests that nations contributing $1 billion within the first year could bypass term limits and secure a permanent seat. The White House has pushed back on the reports, calling them misleading and insisting that no mandatory membership fee exists. Officials acknowledged that major financial contributors could receive greater influence but ...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment